Working…
ClinicalTrials.gov

Key Record Dates

ClinicalTrials.gov Identifier: NCT02186821
Brief Title: Ceritinib (LDK378) for Patients Whose Tumors Have Aberrations in ALK or ROS1 (SIGNATURE) (SIGNATURE)

First Submitted : July 3, 2014
First Submitted that Met QC Criteria : July 8, 2014
First Posted : July 10, 2014 (Estimate)

Results First Submitted : December 11, 2018
Results First Submitted that Met QC Criteria : March 12, 2021
Results First Posted : April 8, 2021

Last Update Submitted that Met QC Criteria : March 12, 2021
Last Update Posted : April 8, 2021